Reduction of Toxicity by Reversing the Order of Infusion of Docetaxel and Cyclophosphamide

Publisher： Karger

E-ISSN： 1421-9794|59|2|93-98

ISSN： 0009-3157

Source： Chemotherapy, Vol.59, Iss.2, 2013-08, pp. : 93-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Randomised Phase II Trial Comparing Docetaxel Plus Prednisone with Docetaxel Plus Prednisone Plus Low-Dose Cyclophosphamide in Castration-Resistant Prostate Cancer

By  

Chemotherapy, Vol. 60, Iss. 2, 2015-02 ,pp. : 129-134

Karger

Access to resources Recommend Favorite

Aflatoxin Toxicity Reduction in Feed by Enhanced Binding to Surface-Modified Clay Additives

By Jaynes William F.   Zartman Richard E.  

Toxins, Vol. 3, Iss. 6, 2011-06 ,pp. : 551-565

MDPI

Access to resources Recommend Favorite

Relationship between Prostatic α1-Adrenoceptor Binding and Reduction in Intraurethral Pressure following Continuous Infusion of KMD-3213 in Rats

By  

Pharmacology, Vol. 64, Iss. 3, 2002-02 ,pp. : 140-147

Karger

Access to resources Recommend Favorite

Computer-Aided Targeting of the PI3K/Akt/mTOR Pathway: Toxicity Reduction and Therapeutic Opportunities

By Li Tan   Wang Guanyu  

International Journal of Molecular Sciences, Vol. 15, Iss. 10, 2014-10 ,pp. : 18856-18891

MDPI

Access to resources Recommend Favorite

A Phase I Study of Docetaxel and Bexarotene

By  

Chemotherapy, Vol. 54, Iss. 2, 2008-03 ,pp. : 125-130

Karger

Access to resources Recommend Favorite